“We became an analytical powerhouse before we started offering integrated process development and manufacturing. That’s what differentiates us.” Sigma Mostafa, Chief Scientific Officer, and Katie Edgar, Chief Business Officer at KBI Biopharma, explain how technical depth in analytics and proprietary
“Despite the volatility, the industry is getting some positive energy and renewed confidence” Jeremie Trochu, Chief Executive Officer at Ardena, has spent two decades building and scaling businesses across the biopharma sector. He was part of the leadership team that
“Life has not become simpler and easier. It’s become more complex. Success requires acknowledging this complexity early and building flexibility into every aspect of the business model.” Renée Aguiar-Lucander is the CEO of Hansa Biopharma, appointed in April 2025. Renée
“Poland is no longer an emerging market. It’s a partnering market.” Dr. Magdalena Kulczycka, founder of the Biotech Innovation Institute, is a molecular biologist with experience spanning academia, entrepreneurship, and venture capital. Her institute fosters biotech growth from lab to
“We invest emotionally and intellectually in their journey—when their product reaches patients, that’s our success too.” Janet Hoogstraate, CEO of NorthX Biologics, brings ~30 years of pharmaceutical experience spanning from preclinical development to GMP production for marketed products, with leadership
“The differentiator in our business isn’t the equipment and the facility—it’s the scientists working with customers to create assays and solve complex scientific challenges.” Leon Wyszkowski has spent nearly three decades in drug development, including 20 years at Thermo Fisher
“The Basel cluster has such a long history—it’s about chemistry meeting innovation, trading roots, and an open mindset. That unique mix created something remarkable.” Dr. Christof Klöpper, CEO of Basel Area Business & Innovation, brings a rare combination of academic
“It costs about $2.5 billion to bring a drug to the market, and only about 30% of those actually succeed or meet their commercial goals when they get to the market.” Manufacturing leaders typically focus on the technical challenges directly
“The key word is curiosity. That curiosity helps you to question and improve not only yourself, but also your processes, your systems, and how you interact with different stakeholders.” Jeroen Janssens, External Manufacturing Technical Operations Lead at MSD, provides insights
“We have strong scientific foundations and manufacturing excellence. Now we’re creating the ecosystem to help biotechs scale and compete globally,” says Federico Vigano, Board Member of Assobiotec. Federico Vigano, Country Manager for Vertex in Italy and Greece, brings extensive pharmaceutical
